reglab/housing_qa huggingface dataset:
CA Health & Safety Code § 104151 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.3 - Breast and Cervical Cancer Early Detection Program Grant|Section 104151.

104151.  (a) Notwithstanding Section 10231.5 of the Government Code, each year, by no later than January 10 and concurrently with the release of the May Revision, the State Department of Health Care Services shall provide the fiscal committees of the Legislature with an estimate package for the Every Woman Counts Program. This estimate package shall include all significant assumptions underlying the estimate for the Every Woman Counts Program’s current-year and budget-year proposals, and shall contain concise information identifying applicable estimate components, such as caseload; a breakout of costs, including, but not limited to, clinical service activities, including office visits and consults, screening mammograms, diagnostic mammograms, diagnostic breast procedures, case management, and other clinical services; policy changes; contractor information; General Fund, special fund, and federal fund information; and other assumptions necessary to support the estimate.(b) Notwithstanding Section 10231.5 of the Government Code, each year, the State Department of Health Care Services shall provide the fiscal and appropriate policy committees of the Legislature with biannual updates on caseload, estimated expenditures, and related program monitoring data for the Every Woman Counts Program. These updates shall be provided no later than February 28 and August 31 of each year. The purpose of the updates is to provide the Legislature with the most recent information on the program, and shall include a breakdown of expenditures for each six-month period for clinical service activities, including, but not limited to, office visits and consults, screening mammograms, diagnostic mammograms, diagnostic breast procedures, case management, and other clinical services. This subdivision supersedes the requirements of Section 169 of Chapter 717 of the Statutes of 2010 (SB 853).(c) Commencing with the 2017–18 fiscal year, expenditures for the Every Woman Counts Program included in the department’s budget for services provided on or after July 1, 2017, shall be charged against the appropriation for the fiscal year in which the billing is paid.(Amended by Stats. 2017, Ch. 52, Sec. 13. (SB 97) Effective July 10, 2017.)
CA Health & Safety Code § 104160 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.5 - Breast and Cervical Cancer Treatment Program|Section 104160.

104160.  (a) The State Department of Health Care Services shall develop and maintain the Breast and Cervical Cancer Treatment Program to expand and ensure quality breast and cervical cancer treatment for low-income uninsured and underinsured individuals who are diagnosed with breast or cervical cancer.(b) To implement the program, the State Department of Health Care Services may contract with public or private entities, or utilize existing health care service provider enrollment and payment mechanisms, including the Medi-Cal program’s fiscal intermediary, only if services provided under the program are specifically identified and reimbursed in a manner that does not claim federal financial reimbursement. The utilization of the Medi-Cal program’s fiscal intermediary shall not be subject to Chapter 3 (commencing with Section 12100) of Part 2 of Division 2 of the Public Contract Code. Contracts to implement the program entered into by the State Department of Health Care Services with entities other than the Medi-Cal program’s fiscal intermediary shall not be subject to Part 2 (commencing with Section 10100) of Division 2 of the Public Contract Code.(Amended by Stats. 2012, Ch. 23, Sec. 20. (AB 1467) Effective June 27, 2012.)
CA Health & Safety Code § 104161 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.5 - Breast and Cervical Cancer Treatment Program|Section 104161.

104161.  For the purposes of this article, the following definitions shall apply:(a) “Covered conditions” means breast or cervical cancer.(b) “Breast cancer” includes primary, recurrent, and metastatic cancers of the breast, including, but not limited to, infiltrating or in situ.(c) “Cervical cancer” includes all primary, recurrent, and metastatic cancers of the cervix, including, but not limited to, infiltrating or in situ, as well as cervical dysplasia.(d) “Treatment services” means those health care services, goods, supplies, or merchandise medically necessary to treat the covered condition or conditions with which the individual made eligible under this article has been diagnosed.(e) “Uninsured” means not covered for breast or cervical cancer treatment services by any of the following:(1) No-cost full-scope Medi-Cal.(2) Medicare.(3) A health care service plan contract or policy of disability insurance.(4) Any other form of health care coverage.(f) “Underinsured” means either of the following:(1) Covered for breast or cervical cancer treatment services by any health care insurance listed in paragraph (2), (3), or (4) of subdivision (e), but the sum of the individual’s insurance deductible, premiums, and expected copayments in the initial 12-month period that breast or cervical cancer treatment services are needed exceeds seven hundred fifty dollars ($750).(2) Covered by share-of-cost or limited-scope Medi-Cal, if the individual is not otherwise eligible for treatment services under the Medi-Cal program pursuant to Section 14007.71 of the Welfare and Institutions Code.(Amended by Stats. 2018, Ch. 34, Sec. 8. (AB 1810) Effective June 27, 2018.)
CA Health & Safety Code § 104161.1 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.5 - Breast and Cervical Cancer Treatment Program|Section 104161.1.

104161.1.  (a) If an individual is made eligible for treatment services under this article due to a diagnosis of breast cancer, the treatment services shall be provided for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.(b) If an individual is made eligible for treatment services under this article due to a diagnosis of cervical cancer, the treatment services shall be provided for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.(c) If an individual is diagnosed with a reoccurrence of breast cancer or cervical cancer, whether at the original cancer site or a different cancer site, the individual shall be eligible for coverage for the duration of the period of treatment, as long as the individual continues to meet all other eligibility requirements.(Amended by Stats. 2018, Ch. 34, Sec. 9. (AB 1810) Effective June 27, 2018.)
CA Health & Safety Code § 104162 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.5 - Breast and Cervical Cancer Treatment Program|Section 104162.

104162.  An individual shall be eligible to receive treatment services pursuant to this article provided that all of the following criteria are met:(a)  The individual is a resident of California. (b)  The individual is uninsured or underinsured. (c)  The individual, who meets the income standards described in subdivision (d), was screened for breast or cervical cancer by a provider or entity participating in the Centers for Disease Control and Prevention breast and cervical cancer early detection program established under Title XV of the Public Health Service Act (42 U.S.C. Sec. 300k et seq.) in accordance with requirements of Section 1504 of that act (42 U.S.C. Sec. 300n) and needs treatment for breast or cervical cancer. (d)  As determined by the provider performing the screening and diagnosis, the individual has family income at or below 200 percent of the federal poverty level. (e)  The individual has filed a completed application for eligibility for treatment services under the Medi-Cal program pursuant to Section 14007.71 of the Welfare and Institutions Code, and has been found ineligible for benefits under that section. (Repealed and added by Stats. 2001, Ch. 171, Sec. 9. Effective August 10, 2001. Operative January 1, 2002, by Sec. 59 of Ch. 171.)
CA Health & Safety Code § 104162.1 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.5 - Breast and Cervical Cancer Treatment Program|Section 104162.1.

104162.1.  If an individual is underinsured, as defined in subdivision (f) of Section 104161, the State Department of Health Care Services shall be the payer of second resort for treatment services. To the extent necessary for the individual to obtain treatment services under any health care insurance listed in paragraph (2), (3), or (4) of subdivision (e) of Section 104161, the State Department of Health Care Services may do the following:(a) Pay for the individual’s breast or cervical cancer copayments, premiums, and deductible.(b) Provide only treatment services not otherwise covered by any health care insurance listed in paragraph (2), (3), or (4) of subdivision (e) of Section 104161.(Amended by Stats. 2018, Ch. 34, Sec. 10. (AB 1810) Effective June 27, 2018.)
CA Health & Safety Code § 104162.2 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.5 - Breast and Cervical Cancer Treatment Program|Section 104162.2.

104162.2.  For the purposes of establishing eligibility for treatment services under this article, breast or cervical cancer screens performed by providers or entities not described in subdivision (c) of Section 104162 may be used only to the same extent the screens are used by the Medi-Cal program for the purpose of determining eligibility pursuant to Section 14007.71 of the Welfare and Institutions Code, as approved by the federal Health Care Financing Administration.(Added by Stats. 2001, Ch. 171, Sec. 9. Effective August 10, 2001. Operative January 1, 2002, by Sec. 59 of Ch. 171.)
CA Health & Safety Code § 104163 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.5 - Breast and Cervical Cancer Treatment Program|Section 104163.

104163.  The State Department of Health Care Services shall provide for breast cancer and cervical cancer treatment services pursuant to this article at the level of funding budgeted from state and other resources during the fiscal year in which the Legislature has appropriated funds to the department for this purpose. These treatment services shall not be deemed to be an entitlement.(Amended by Stats. 2012, Ch. 23, Sec. 22. (AB 1467) Effective June 27, 2012.)
CA Health & Safety Code § 104170 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 1.7 - Human Leukocyte Antigen Testing Fund|Section 104170.

104170.  (a)  The Human Leukocyte Antigen Testing Fund is hereby established in the State Treasury, to be administered by the State Department of Health Services. Moneys in the fund shall be subject to appropriation in the annual Budget Act, and shall be used to pay the costs of blood collection and human leukocyte antigen typing, also referred to as histocompatibility locus antigen (HLA) testing, for A, B, and DR antigens for use in bone marrow transplantation by California blood centers under contract with the federal National Marrow Donor Program provided for pursuant to Public Law 101-302. (b)  Moneys in the fund may only be expended if the individual being tested completes and signs an informed consent form authorizing the use of test results for participation in the federal program referred to in subdivision (a). The form shall require a declaration from the donor as to whether he or she has health plan benefits that would cover the cost of HLA testing. Moneys in the fund shall not be used to pay for the testing of a health plan enrollee if the health plan covers the cost of HLA testing for the enrollee. (Amended by Stats. 2001, Ch. 159, Sec. 132. Effective January 1, 2002.)
CA Health & Safety Code § 104175 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104175.

104175.  The Legislature finds and declares that decades after the war on cancer was declared, it remains an insidious killer of Californians. Simultaneously, cancer absorbs millions of dollars from California’s economy through health care costs, and takes an horrendous toll on the personal lives of citizens.(Added by Stats. 1997, Ch. 756, Sec. 1. Effective January 1, 1998.)
CA Health & Safety Code § 104180 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104180.

104180.  The Cancer Research Fund is hereby established in the State Treasury. Moneys in the fund shall be available for expenditure by the department, upon appropriation by the Legislature. The fund shall consist of money accepted by the department from grants and donations from private entities and of public moneys transferred to the fund. It is the intent of the Legislature that, after the initial appropriation made pursuant to Assembly Bill 1554 of the 1997–98 Regular Session, the fund be enhanced by annual allocations determined in subsequent budget acts.(Amended by Stats. 2001, Ch. 246, Sec. 1. Effective September 5, 2001.)
CA Health & Safety Code § 104181.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104181.5.

104181.5.  The department, in awarding grants under this program, shall not encumber money allocated in any fiscal year other than the fiscal year in which the appropriation was made beginning with nonobligated 2000–01 fiscal year funds, subject to receiving multiyear spending authority for those funds.(Added by Stats. 1999, Ch. 751, Sec. 1. Effective January 1, 2000.)
CA Health & Safety Code § 104181.6 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104181.6.

104181.6.  Notwithstanding subdivision (a) of Section 2.00 of the Budget Act of 2002 and any other provision of law, commencing with the appropriation for the 2002–03 fiscal year, and for each fiscal year thereafter, any amount appropriated to the department for the Cancer Research Program shall be available, for purposes of that program, for encumbrance for one fiscal year beyond the year of appropriation and for expenditure for three fiscal years beyond the year of encumbrance.(Added by Stats. 2003, Ch. 230, Sec. 6. Effective August 11, 2003.)
CA Health & Safety Code § 104182 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104182.

104182.  (a)  The Cancer Research Council is hereby established, to consist of 15 members appointed by the Director of Health Services representing a range of expertise and experience, and the chief of the California Cancer Registry as an ex officio, nonvoting member. The voting members shall be appointed by February 15, 1998, as follows: (1)  Nine members from persons recommended by relevant organizations, as follows: (A)  One member drawn from a cancer survivor group or cancer-related advocacy group. (B)  Five members drawn from the ranks of scientists or clinicians, two from public universities or research organizations, and three from private universities or research organizations. The scientists shall have expertise in one or more of the various fields of cancer research. (C)  One member who is a practicing cancer medical specialist from a health organization with a commitment to cancer research and control. (D)  Two members from private industry with an interest in cancer research and control, including, but not limited to, entrepreneurs or persons from the science or high technology industry. (2)  Three members nominated by the Senate Committee on Rules as follows: (A)  One member drawn from a cancer survivor group or cancer-related advocacy group. (B)  One member drawn from a health organization. (C)  One member drawn from private industry with an interest in cancer research or control. (3)  Three members nominated by the Speaker of the Assembly as follows: (A)  One member drawn from a cancer survivor group or cancer-related advocacy group. (B)  One member drawn from a health organization. (C)  One scientist or clinician who has expertise in one or more of the various fields of cancer research. (b)  It is the intent of the Legislature that the council contain the proportional representation of appointees described in subdivision (a) when the council approves the funding of research grants, and that vacancies affecting the proportional representation be filled before grants are approved, and within 45 days of the occurrence of a vacancy. (c)  Members shall serve without compensation, but may receive reimbursement for travel and other necessary expenses actually incurred in the performance of their official duties. (d)  All appointments shall be for a term of four years, except that, for purposes of the initial appointments, the Director of Health Services shall appoint five members to four-year terms, five members to three-year terms, and five members to two-year terms. Each of those groups of five members shall include three members appointed under paragraph (1) of subdivision (a), one member appointed under paragraph (2) of that subdivision, and one member appointed under paragraph (3) of that subdivision. (Added by Stats. 1997, Ch. 755, Sec. 3. Effective January 1, 1998.)
CA Health & Safety Code § 104182.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104182.5.

104182.5.  Not less than a majority of the appointed members of the Cancer Research Council shall be present and voting for approval and selection of research priorities under Section 104185 and ultimate recommendations to the State Department of Health Services regarding grantmaking decisions.(Added by Stats. 1999, Ch. 751, Sec. 2. Effective January 1, 2000.)
CA Health & Safety Code § 104182.7 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104182.7.

104182.7.  (a)  The department shall grant a minimum of 65 percent of any fiscal year appropriation that is awarded for research to cancer research proposals directly researching gender-specific cancers. (b)  Any amount of funding for gender-specific cancer research for any fiscal year, to the extent the amount is below the threshold minimum allocation for any fiscal year established pursuant to subdivision (a), shall be carried forward, upon approval of the council for the following fiscal year or years for gender-specific cancer research, to the extent allowed by the limitations on the appropriated funds subject to that allocation. Funding allocations carried over from any fiscal year under this subdivision shall be in addition to the funding allocation for gender-specific cancer research for fiscal years to which the additional allocation is transferred pursuant to this subdivision. (Added by Stats. 1999, Ch. 751, Sec. 3. Effective January 1, 2000.)
CA Health & Safety Code § 104187.5 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104187.5.

104187.5.  Peer review panels, in reviewing proposals for cancer research, may recommend the awarding of a grant to a cancer research proposal on the condition that a single adjustment or correction be made before the receipt of funding under this article.(Added by Stats. 1999, Ch. 751, Sec. 5. Effective January 1, 2000.)
CA Health & Safety Code § 104188 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104188.

104188.  The maximum indirect cost rate that may be charged on any cancer research program grant awarded to any institution under this article shall not be more than 25 percent of the institution’s direct costs.(Added by Stats. 2002, Ch. 1161, Sec. 9. Effective September 30, 2002.)
CA Health & Safety Code § 104189 (2021)
2021 California Code|Health and Safety Code - HSC|DIVISION 103 - DISEASE PREVENTION AND HEALTH PROMOTION|PART 1 - CHRONIC DISEASE|CHAPTER 2 - Cancer|ARTICLE 2 - The Cancer Research Act of 1997|Section 104189.

104189.  The responsibilities of the council shall include, but not be limited to, all of the following:(a)  Development and review of the strategic objectives and research priorities of the program. (b)  Delineation of resource allocation across the various priorities established for the program. (c)  Participation in periodic program and financial review, including the report transmitted pursuant to subdivision (i) of Section 104187. (d)  Development and review of guidelines to ensure fairness, neutrality, and adherence to the principles of merit and quality in the conduct of the program. (e)  Development of appropriate linkages to nonacademic entities, including, but not limited to, voluntary organizations, health care delivery systems, industry, government agencies, research entrepreneurs, and public officials. (f)  Development and review of criteria and standards for granting awards. (g)  Oversight and review of the request for applications (RFA). (h)  Review of research review panel reports and recommendations for grant awards. (i)  Make recommendations relating to the grants that are to be awarded. (j)  Development and review of oversight mechanisms for the dissemination of research results. (k)  Development and review of policies and liaison programs to facilitate the translation of research results into commercial, alternate technological, or other applications wherever appropriate. ( l)  Establishment of its own internal rules of operation. (m)  Participation in the identification and recruitment of scientists with relevant expertise for possible participation in a peer review panel. The council may propose to assign a member of the council to sit as a nonvoting member of the peer review panels. (Added by Stats. 1997, Ch. 756, Sec. 1. Effective January 1, 1998.)